Supplementary Fig. S12 from Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer

Key Points

• Mutation burden varies with intestinal metaplasia, influencing gastric cancer outcomes and treatment options.
• Key evidence shows a significant difference in mutation rates between intestinal metaplasia of intestinal-type and diffuse-type gastric cancer.
• Comparative genomic analysis focuses on the mutation burden related to intestinal metaplasia in gastric cancer subtypes.
• The findings suggest potential implications for individualized therapies targeting specific gastric cancer characteristics.